Yüklüyor......
Biologics increase the risk of SARS‐CoV‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration
During COVID‐19 outbreak there are discordant opinions toward the impact of biologics in psoriatic (PsO) patients. Thus we performed a single‐center case‐control study in Lombardia, the Italian region with the higher number of COVID‐19 confirmed cases. We enrolled 1193 PsO patients treated with biol...
Kaydedildi:
| Yayımlandı: | Dermatol Ther |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7261990/ https://ncbi.nlm.nih.gov/pubmed/32356577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.13475 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|